Breast Cancer Clinical Trial
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Summary
RATIONALE: Gathering information about patients with breast cancer and their families may help the study of breast cancer in the future.
PURPOSE: This clinical trial is gathering information about patients with breast cancer and their families.
Full Description
OBJECTIVES:
To develop a web-based Breast Cancer Collaborative Registry (BCCR) as a repository for socio-demographic, environmental, clinical history, family history, and biospecimen data collected at the National Comprehensive Cancer Network (NCCN) centers for participants with a personal history of breast cancer and/or characteristics of hereditary breast cancer.
To merge the data already being collected on breast cancer patients under the Adult Oncology Data Collection Study and newly diagnosed breast cancer patients participating in the NCCN Data Coordinating study at UNMC/NMC.
To standardize clinical, environmental, socio-demographic, and family history data for breast cancer-related information to be collected and shared for research purposes by Eppley Breast Cancer Research Group breast cancer research collaborators.
To collect, validate, and disseminate the breast cancer-related data to establish a high-risk cohort for future research into the molecular and biological bases of breast cancer susceptibility and interventional trials.
OUTLINE: This is a multicenter study.
Study participants undergo data collection related to breast cancer studies at one of the National Comprehensive Cancer Network (NCCN) centers for inclusion in the Breast Cancer Collaborative Registry (BCCR). The BCCR is a comprehensive computerized database that serves as a repository for socio-demographic, environmental, clinical history, family history, and biospecimen data collected for breast cancer patients treated on UNMC protocols. Central features of the registry include standardized data-entry forms and a relational database that can be used as a resource for the study of the pathology, immunology, cytogenetics, molecular biology, epidemiology, clinical features, and outcome of patients with benign, pre-malignant, or malignant breast disease.
Study participants complete a self-administered electronic or paper-based survey and a medical history questionnaire at baseline to provide information on demographics (e.g., age and sex); personal and family medical history; treatment history; lifestyle, physical activity, and dietary habits; quality of life; environmental exposure history; and the family tree for inclusion in the registry. Participants also undergo telephone or in-person structured interviews conducted by study coordinators, genetic counselors, or the System Coordinator of the BCCR to provide additional information or clarification of the information provided in the questionnaires.
Study participants also undergo review of their medical records and pathology reports to obtain detailed medical and treatment-related information for inclusion in the registry. The information collected includes retrospective and prospective disease-specific data (e.g., diagnosis, grade/stage, and laboratory values) and longitudinal outcome data (e.g., response to treatment, toxicity, survival, relapse) derived during prospective clinical follow-up.
Study participants are followed periodically to update relevant health and family histories.
Eligibility Criteria
Inclusion Criteria:
Current diagnosis or history of breast cancer
Atypical hyperplasia
Ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006
Characteristics of hereditary breast cancer, as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006 (relatives have been diagnosed with breast and/or ovarian cancer) OR have a breast cancer risk of > 1.67% over 5 years as estimated by the GAIL Model
Exclusion Criteria:
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 57 Locations for this study
Colorado Springs Colorado, 80907, United States
Denver Colorado, 80210, United States
Lakewood Colorado, 80228, United States
Parker Colorado, 80138, United States
Pueblo Colorado, 81004, United States
Daytona Beach Florida, 32114, United States
Daytona Beach Florida, 32117, United States
Daytona Beach Florida, 32127, United States
DeLand Florida, 32720, United States
Orange City Florida, 32763, United States
Ormond Beach Florida, 32174, United States
Palm Coast Florida, 32164, United States
Aurora Illinois, 60504, United States
Moline Illinois, 61265, United States
Yorkville Illinois, 60560, United States
Anderson Indiana, 46011, United States
Anderson Indiana, 46011, United States
Anderson Indiana, 46011, United States
Indianapolis Indiana, 46219, United States
Indianapolis Indiana, 46227, United States
Indianapolis Indiana, 46256, United States
Council Bluffs Iowa, 51503, United States
Davenport Iowa, 52804, United States
Davenport Iowa, 52804, United States
Mason City Iowa, 50401, United States
Spencer Iowa, 51301, United States
Waterloo Iowa, 50702, United States
Overland Park Kansas, 66213, United States
New Orleans Louisiana, 70112, United States
Lewiston Maine, 04240, United States
Lewiston Maine, 04240, United States
Lewiston Maine, 04240, United States
Lewiston Maine, 04240, United States
Lewiston Maine, 04240, United States
Hagerstown Maryland, 21742, United States
Westminster Maryland, 21157, United States
Holyoke Massachusetts, 01040, United States
Plymouth Massachusetts, 02360, United States
Joplin Missouri, 64804, United States
Kansas City Missouri, 64086, United States
Kansas City Missouri, 64111, United States
Kansas City Missouri, 64118, United States
Liberty Missouri, 64068, United States
Saint Joseph Missouri, 64506, United States
Saint Joseph Missouri, 64507, United States
Hastings Nebraska, 68901, United States
Kearney Nebraska, 68847, United States
Norfolk Nebraska, 68701, United States
North Platte Nebraska, 69101, United States
Omaha Nebraska, 68198, United States
Scottsbluff Nebraska, 69361, United States
Glens Falls New York, 12801, United States
Utica New York, 13501, United States
Utica New York, 13502, United States
Utica New York, 13502, United States
Fayetteville North Carolina, 28304, United States
Minot North Dakota, 58701, United States
Aberdeen South Dakota, 57401, United States
Mitchell South Dakota, 57301, United States
Sioux Falls South Dakota, 57105, United States
Rutland Vermont, 05701, United States
Brookfield Wisconsin, 53045, United States
Franklin Wisconsin, 53132, United States
Racine Wisconsin, 53405, United States
Wauwatosa Wisconsin, 53226, United States
How clear is this clinincal trial information?